ProQR (PRQR) director Alison Lawton details multiple option grants
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
ProQR Therapeutics N.V. director Alison Frances Lawton filed an initial ownership report listing multiple share option awards over Ordinary Shares. These options have exercise prices ranging from 1.9800 to 15.7800 and expiration dates between 2026 and 2035, all held directly.
Footnotes explain that some options are fully vested, while others vest over time. For several grants, 25% of the shares vest on January 1 of 2024, 2025, 2026, or 2027, with the remaining 75% vesting in 12 substantially equal quarterly installments, subject to her continuous service to the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
11 transactions reported
Mixed
11 txns
Insider
Lawton Alison Frances
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Share Option (Right to Buy) — 5,815 shares (Direct)
Footnotes (1)
- Fully vested. 25% of the shares subject to such option vest and become exercisable on January 1, 2024, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. 25% of the shares subject to such option vest and become exercisable on January 1, 2025, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. 25% of the shares subject to such option vest and become exercisable on January 1, 2026, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. 25% of the shares subject to such option vest and become exercisable on January 1, 2027, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
FAQ
What does the ProQR (PRQR) Form 3 filing for Alison Frances Lawton show?
The Form 3 shows Alison Frances Lawton’s initial beneficial ownership in ProQR through multiple share option awards over Ordinary Shares, all held directly, with specified exercise prices, expiration dates, and detailed vesting schedules tied to continued service.
What are the vesting terms for Alison Lawton’s ProQR (PRQR) options?
For multiple option grants, 25% of the shares vest and become exercisable on January 1 of 2024, 2025, 2026, or 2027. The remaining 75% then vest in 12 substantially equal quarterly installments, contingent on Alison Lawton’s continuous service to ProQR.
What exercise price range is disclosed for ProQR (PRQR) options held by Alison Lawton?
The filing lists several direct share option positions with exercise prices including 1.9800, 2.0200, 2.6500, 3.3000, 3.4100, 4.2000, 4.8900, 4.9000, 8.0100, 9.9100, and 15.7800, each tied to specific expiration dates between 2026 and 2035.
When do Alison Lawton’s ProQR (PRQR) options expire?
The disclosed share options over ProQR Ordinary Shares have staggered expiration dates, including June 20, 2026, December 31 of 2026, 2027, 2028, 2029, 2030, 2032, 2033, 2034, and 2035, reflecting a long-dated incentive structure for the director.